Abstract:Objective To observe the effect of systemic combined with intratympanic injection of glucocorticoids at different times in the treatment of severe sudden sensorineural hearing loss, to explore the timing of intratympanic injection, and to analyze the factors affecting the prognosis of severe to profound sudden sensorineural hearing loss.Methods It was retrospectively analyzed for the clinical data and treatment effects of 108 patients with severe to profound sudden sensorineural hearing loss. The patients were divided into two groups. One group is systemic combined initial intratympanic injection of dexamethasone, and the other group is systemic combined delayed intratympanic injection of dexamethasone. The curative effects of the two groups were compared at discharge and follow-up. It was analyzed for the clinical features of the effective group and the ineffective group.Results There was no significant difference for the average hearing threshold, the average hearing threshold elevation, and the total effective rate between the two treatment options at discharge and follow-up (all P>0.05). However, the difference of the recovery rate was statistically significant (P<0.05). There were statistically significant differences for the two treatment regimens between before treatment and at discharge, between before treatment and at follow-up (all P<0.001). Among 108 patients, 83 cases (76.9%) were effective. The patients with vertigo had a low effective rate (P<0.05).The effective rate of treatment was correlated with the degree of initial hearing threshold loss (P<0.05) and the type of hearing curve (P<0.05), but had no significant correlation with age, gender, side and tinnitus (P>0.05). The treatment effective rate was related to the degree of the initial hearing threshold loss (P<0.05) and the type of hearing curve (P<0.05), but had no significant correlation with age, gender, side and tinnitus (all P>0.05).Conclusions For severe to profound sudden sensorineural hearing loss, the degree of hearing loss, the type of curve, and vertigo are associated with the prognosis of patients. It is recommended to use the treatment of systemic combined with intratympanic corticosteroids as soon as possible in treatment.